Vaccine lawsuits – Justices divided

NewsGuard 100/100 Score

The US Supreme Court is seemingly divided over the lawsuits on childhood vaccines. The Justices acquiesced that the Congress has done its bit to shield vaccine-makers from suits by the few who have had an adverse reaction to a vaccine approved by the Food and Drug Administration. Now the matter revolves around whether those hurt by vaccines have the right to sue manufacturers if they can prove that a safer version was available.

David C. Frederick, a Washington lawyer says, “We are talking about trying to eliminate some of the most horrifying and horrible incidents of injury to vaccines that we compel children to take.” He is representing the parents of Hannah Bruesewitz, 18, who began to have seizures as an infant after receiving the third of five scheduled doses of Wyeth's Tri-Immunol diphtheria-pertussis-tetanus vaccine. The company, now owned by Pfizer, has taken the drug off the market.

The National Childhood Vaccine Injury Act of 1986 says that all such claims must first go to a special tribunal commonly called the “Vaccine Court”. The tribunal ruled against the Bruesewitzes, saying they had not proved that the vaccine caused Hannah's problems.

Kathleen Sullivan, representing Wyeth said that the Congress's intent was clear, and that it acted “against the backdrop of a wave of tort litigation that threatened to drive manufacturers out of the business of providing the vaccine.” She added that, “There are 5,000 claimants in vaccine court now who claim there is a relationship between the mumps, measles, and rubella vaccine and autism.” She faced some tough questions from Justices Sonia Sotomayor and Ruth Bader Ginsburg.

Sotomayor feels that without the fear of a lawsuit, “what is the motivation for manufacturers to voluntarily remove a drug that is causing harm to the public before the FDA acts?”

Frederick's tough questions came from Chief Justice John G. Roberts Jr. and Justices Antonin Scalia and Samuel A. Alito Jr. Frederick told the court that the industry was protected by Congress in 99 percent of the cases.

Tens of millions of childhood vaccine doses are safely administered each year in the US. Roughly 100 to 200 claims related to adverse effects are submitted each year for compensation. To date, the compensation fund has paid out $1.8 billion to 2,500 petitioners. The average award is about $750,000. In addition, the government spends roughly $2 billion a year for research and development of safer vaccines.

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2020, April 03). Vaccine lawsuits – Justices divided. News-Medical. Retrieved on April 25, 2024 from https://www.news-medical.net/news/20101012/Vaccine-lawsuits-Justices-divided.aspx.

  • MLA

    Mandal, Ananya. "Vaccine lawsuits – Justices divided". News-Medical. 25 April 2024. <https://www.news-medical.net/news/20101012/Vaccine-lawsuits-Justices-divided.aspx>.

  • Chicago

    Mandal, Ananya. "Vaccine lawsuits – Justices divided". News-Medical. https://www.news-medical.net/news/20101012/Vaccine-lawsuits-Justices-divided.aspx. (accessed April 25, 2024).

  • Harvard

    Mandal, Ananya. 2020. Vaccine lawsuits – Justices divided. News-Medical, viewed 25 April 2024, https://www.news-medical.net/news/20101012/Vaccine-lawsuits-Justices-divided.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Nigeria first to rollout new Men5CV vaccine against meningitis